0.9474
0.28%
0.0026
Handel nachbörslich:
.95
0.0026
+0.27%
Neuronetics Inc Aktie (STIM) Neueste Nachrichten
Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults - StockTitan
Neuronetics Enhances NeuroStar Therapy with New Features - MyChesCo
Acadian Asset Management LLC Purchases 62,628 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Greenbrook TMS announces acquisition by Neuronetics - Investing.com Canada
Greenbrook TMS announces acquisition by Neuronetics - Investing.com
STIM’s Stock Swings: Riding the 2023 Wave of Ups and Downs - The InvestChronicle
Greenbrook TMS announces acquisition by Neuronetics - Investing.com India
Greenbrook TMS Nears Acquisition by Neuronetics, Shareholders to Vote - TipRanks
Investing in Neuronetics Inc (STIM): What You Must Know - Knox Daily
Financial Health Check: Examining Neuronetics Inc (STIM)’s Key Ratios - The Dwinnex
NeuroStar® Releases Software Upgrades to Elevate Patient Care - StockTitan
Neuronetics Inc (STIM) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
Neuronetics director Robert Cascella buys $75k of company stock - Investing.com India
Neuronetics director Robert Cascella buys $75k of company stock By Investing.com - Investing.com Australia
Neuronetics director Robert Cascella buys $75k of company stock - Investing.com
Transcranial Magnetic Stimulator Market Huge Growth in Future - openPR
Neuronetics' Breakthrough: How NeuroStar Therapy Is Transforming Lives Amid Rising Suicide Rates - MyChesCo
Neuromodulation Market Projected for Strong Growth by 2031 | - openPR
North America Deep Transcranial Magnetic Stimulation Device Market By Applications - அக்னி செய்திகள்
NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories - StockTitan
Butterfly Network And 3 Other Stocks Under $2 Executives Are Aggressively BuyingNeuronetics (NASDAQ:STIM) - Benzinga
Deeper Dive: Understanding Neuronetics Inc (STIM) Through its Various Ratios - The Dwinnex
Neuronetics, Inc. (NASDAQ:STIM) Director Purchases $10,859.60 in Stock - Defense World
Neuronetics director Glenn Muir acquires $21,250 in company stock By Investing.com - Investing.com Australia
Neuronetics director Glenn Muir acquires $21,250 in company stock - Investing.com
William Blair downgrades Neuronetics Inc (STIM) rating to a Mkt perform - Knox Daily
Neuronetics (NASDAQ:STIM) shareholders have endured a 85% loss from investing in the stock three years ago - Yahoo Finance UK
Assenagon Asset Management S.A. Raises Position in Neuronetics, Inc. (NASDAQ:STIM) - Defense World
The 6 Most Interesting Behavioral Health Deals of 2024 — So Far - Behavioral Health Business
Neuronetics director Glenn P. Muir buys $25,000 worth of shares By Investing.com - Investing.com Australia
Neuronetics director Glenn P. Muir buys $25,000 worth of shares - Investing.com
Neuronetics director Glenn P. Muir buys $25,000 worth of shares By Investing.com - Investing.com Canada
Neuronetics Celebrates Two Years of NeuroStar University - MyChesCo
Neuronetics director Glenn P. Muir buys $25,000 worth of shares By Investing.com - Investing.com UK
Neuronetics (STIM) Q2 Loss Wider Than Expected, Revenues Fall Y/Y - MSN
Independent Chairman of the Board of Neuronetics Picks Up 33% More Stock - Simply Wall St
Neuronetics director buys $41.7k in company stock By Investing.com - Investing.com Australia
NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University - StockTitan
Neuronetics director buys $41.7k in company stock - Investing.com
Neuronetics director buys $41.7k in company stock By Investing.com - Investing.com Canada
Neuronetics director buys $41.7k in company stock By Investing.com - Investing.com UK
STIM (Neuronetics) Profitability Rank : 1 (As of Jun. 2024) - GuruFocus.com
Robert Cascella Purchases 35,000 Shares of Neuronetics, Inc. (NASDAQ:STIM) Stock - Defense World
Neuronetics director buys $58,450 in company stock - Investing.com India
Glenn Muir acquires $18.9k in Neuronetics shares - Investing.com India
Neuronetics (STIM) Inks a New Merger Agreement With Greenbrook - MSN
Vanguard Group Inc. Sells 53,229 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Glenn Muir acquires $18.9k in Neuronetics shares - Investing.com
Glenn Muir acquires $18.9k in Neuronetics shares By Investing.com - Investing.com Australia
Glenn Muir acquires $18.9k in Neuronetics shares By Investing.com - Investing.com Canada
Glenn Muir acquires $18.9k in Neuronetics shares By Investing.com - Investing.com UK
Neuronetics (NASDAQ:STIM) PT Lowered to $3.00 - Defense World
Neuronetics, Inc. (NASDAQ:STIM) Short Interest Down 18.8% in July - Defense World
Neuronetics director buys $58,450 in company stock - Investing.com
Neuronetics Virtual Event to Discuss Greenbrook Merger Risks - TipRanks
Neuronetics inks Greenbrook merger to acquire treatment centers - MedTech Dive
Neuronetics, Inc. (NASDAQ:STIM) Just Reported, And Analysts Assigned A US$3.33 Price Target - Yahoo Finance
Q3 2024 Earnings Estimate for Neuronetics, Inc. (NASDAQ:STIM) Issued By William Blair - Defense World
Neuronetics inks Greenbrook merger to acquire treatment centers - Yahoo Finance
Neuronetics (STU:NRC) Inventory-to-Revenue : 0.39 (As of Jun. 2024) - GuruFocus.com
Neuronetics Inc (STIM) Q2 2024 Earnings Call Transcript Highligh - GuruFocus.com
Neuronetics to buy Greenbrook TMS in all stock deal - Green Market Report
Neuronetics Second Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Neuronetics Outlines Future Plans and Merger Prospects - TipRanks
Neuronetics Reports Second Quarter 2024 Financial Results and Strategic Developments - MyChesCo
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):